Intraportal Infusion of Ghrelin Could Inhibit Glucose-Stimulated GLP-1 Secretion by Enteric Neural Net in Wistar Rat

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zhang, Xiyao ^a   Li, Wensong ^a   Li, Ping ^a   Chang, Manli ^a   Huang, Xu ^a   Li, Qiang ^a   Cui, Can ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; INCRETIN; PHENTOLAMINE; PRALMORELIN; GLUCOSE BLOOD LEVEL; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DOWN REGULATION; ENTERIC NEURAL NET; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH HORMONE RELEASE; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INTRAPORTAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN SECRETION; RAT; VAGOTOMY; ANIMAL; BLOOD; DRUG EFFECTS; INTESTINE INNERVATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PORTAL VEIN; SECRETION (PROCESS); WISTAR RAT;

RATTUS NORVEGICUS;

ANIMALS; BLOOD GLUCOSE; ENTERIC NERVOUS SYSTEM; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INCRETINS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; PORTAL VEIN; RATS; RATS, WISTAR;

EID: 84919357144     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/923564     Document Type: Article

References (19)

1. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, "Ghrelin is a growth-hormone-releasing acylated peptide fromstomach," Nature, vol. 402, no. 6762, pp. 656-660, 1999.
2. A. M. Wren, C. J. Small, C. R. Abbott et al., "Ghrelin causes hyperphagia and obesity in rats," Diabetes, vol. 50, no. 11, pp. 2540-2547, 2001.
3. A. M. Wren, L. J. Seal, M. A. Cohen et al., "Ghrelin enhances appetite and increases food intake in humans," Journal of Clinical Endocrinology and Metabolism, vol. 86,no. 12,pp. 5992-5995, 2001.
4. H. Ariyasu, K. Takaya, T. Tagami et al., "Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans," The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 10, pp. 4753-4758, 2001.
5. T. Shiiya, M. Nakazato, M. Mizuta et al., "Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion," Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 1, pp. 240-244, 2002.
6. Y. Shimizu, N. Nagaya, T. Isobe et al., "Increased plasma ghrelin level in lung cancer cachexia," Clinical Cancer Research, vol. 9, no. 2, pp. 774-778, 2003.
7. M. Tschöp, C. Weyer, P. A. Tataranni, V. Devanarayan, E. Ravussin, and M. L. Heiman, "Circulating ghrelin levels are decreased in human obesity," Diabetes, vol. 50, no. 4, pp. 707-709, 2001.
8. P. Ceranowicz, Z. Warzecha, A. Dembinski et al., "Treatment with ghrelin accelerates the healing of acetic acid-induced gastric and duodenal ulcers in rats," Journal of Physiology and Pharmacology, vol. 60, no. 1, pp. 87-98, 2009.
9. P. C. Konturek, T. Brzozowski, M. Engel et al., "Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves," Journal of Physiology and Pharmacology, vol. 60, no. 2, pp. 41-47, 2009.
10. A. Karatug, O. Sacan, Z. M. Coskun et al., "Regulation of gene expression and biochemical changes in small intestine of newborn diabetic rats by exogenous ghrelin," Peptides, vol. 33, no. 1, pp. 101-108, 2012.
11. Z. Warzecha, P. Ceranowicz, A. Dembinski et al., "Therapeutic effect of ghrelin in the course of cerulein induced acute pancreatitis in rats," Journal of Physiology and Pharmacology, vol. 61, no. 4, pp. 419-427, 2010.
12. M. Yuan, H. Hu, and C. Huang, "Myocardial angiogenesis after chronic ghrelin treatment in a ratmyocardial infarctionmodel," Regulatory Peptides, vol. 179, no. 1-3, pp. 39-42, 2012.
13. M. Papotti, C. Ghè, P. Cassoni et al., "Growth hormone secretagogue binding sites in peripheral human tissues," Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 10, pp. 3803-3807, 2000.
14. J. Tong, R. L. Prigeon, H. W. Davis et al., "Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans," Diabetes, vol. 59, no. 9, pp. 2145-2151, 2010.
15. C. Cui, H. Ohnuma, M. Daimon et al., "Ghrelin infused into the portal vein inhibits glucose-stimulated insulin secretion in Wistar rats," Peptides, vol. 29, no. 7, pp. 1241-1246, 2008.
16. D. Hagemann, J. J. Holst, A. Gethmann, M. Banasch, W. E. Schmidt, and J. J. Meier, "Glucagon-like peptide 1 (GLP- 1) suppresses ghrelin levels in humans via increased insulin secretion," Regulatory Peptides, vol. 143, no. 1-3,pp. 64-68, 2007.
17. A. Radulescu, M. C. Gannon, and F. Q. Nuttall, "The effect on glucagon, glucagon-like peptide-1, total and acyl-ghrelin of dietary fats ingested with and without potato," Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 7, pp. 3385-3391, 2010.
18. S. M. Pöykkö, E. Kellokoski, S. Hörkkö, H. Kauma, YA. Kesäniemi, and O. Ukkola, "Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes," Diabetes, vol. 52, no. 10, pp. 2546-2553, 2003.
19. A. S. Rocca and P. L. Brubaker, "Role of the vagus nerve in mediating proximal nutrient-induced glucagon- like peptide-1 secretion," Endocrinology, vol. 140, no. 4, pp. 1687-1694, 1999.